Skip to Main content Skip to Navigation
Journal articles

The Biomarkers of Venous Thromboembolism in Cancer Patients

Abstract : Today, the thrombosis associated with cancer is clearly established. The risk of venous thromboembolism (VTE) in cancer is dependent on clinical parameters of cancer patients and the type of tumor. Thus, the relationship between VTE and the type of cancer is complex, caused by the tumor progression, the inflammatory state, and the hemostasis. Several biomarkers had been identified to detect VTE in cancer patients. This review summarizes usual biomarkers, assessed regularly in laboratory and included in risk assessment score, and discusses new biomarkers for prediction of VTE.
Document type :
Journal articles
Complete list of metadata
Contributor : Françoise DIGNAT-GEORGE Connect in order to contact the contributor
Submitted on : Thursday, February 2, 2017 - 4:55:49 PM
Last modification on : Wednesday, November 3, 2021 - 4:16:39 AM




Soraya Mezouar, Roxanne Darbousset, Corinne Frere, Philippe Debourdeau, Dominique Farge-Bancel, et al.. The Biomarkers of Venous Thromboembolism in Cancer Patients. Oncologie, Springer Verlag, 2016, 18 (1), pp.17-21. ⟨10.1007/s10269-015-2579-z⟩. ⟨hal-01453350⟩



Record views